secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harpoon Therapeutics, Inc. (—)
CIK:        0001708493
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227267
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harpoon Therapeutics to effect 1-for-10 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split ratio 1-for-10, effective at 5:00 p.m. ET on September 1, 2023.
- Outstanding shares reduced from ~40.3 million to ~4.0 million shares.
- Common stock will trade on Nasdaq on a split-adjusted basis from September 5, 2023, under ticker HARP.
- No fractional shares issued; stockholders will receive cash for fractional interests.
- CUSIP changed to 41358P205; par value remains $0.0001 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523227267/0001193125-23-227267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708493/000119312523227267/d544436d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer